Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of p-hydroxycinnamic acid or phosphatidylethanolamine in early diagnosis of colorectal cancer

A technology of p-hydroxycinnamic acid and phosphatidylethanolamine, which is applied in the application field of metabolic markers in the early diagnosis of metabolic syndrome and colorectal cancer, can solve the problem of lack of specificity and sensitivity, high time cost and economic cost of verification, and inability to To ensure the accuracy of the results, etc.

Active Publication Date: 2019-07-09
CHINA PHARM UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, there have been many studies on serum markers of colorectal cancer, and many markers have been screened, but most of them still lack specificity and sensitivity, and few studies have verified the screened markers , because the time cost and economic cost of verification are very high, so the accuracy of the result cannot be guaranteed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of p-hydroxycinnamic acid or phosphatidylethanolamine in early diagnosis of colorectal cancer
  • Application of p-hydroxycinnamic acid or phosphatidylethanolamine in early diagnosis of colorectal cancer
  • Application of p-hydroxycinnamic acid or phosphatidylethanolamine in early diagnosis of colorectal cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1: Diagnostic Efficiency of Target Metabolites in Differentiating Healthy Subjects, Patients with Metabolic Syndrome or Patients with Colorectal Cancer

[0042] 1. Experimental samples

[0043] Training set samples: Collect 120 healthy subjects, 120 patients with metabolic syndrome and 120 patients with colorectal cancer who were age- and gender-matched in Xiaoshan area and Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine according to strict screening and exclusion criteria.

[0044] Validation set samples: 580 healthy subjects, 577 patients with metabolic syndrome, and 437 patients with colorectal cancer were collected from Xiaoshan area, Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine, and Taizhou Cancer Hospital according to strict screening and exclusion criteria.

[0045] The inclusion criteria for healthy subjects, patients with metabolic syndrome and patients with colorectal cancer are as follows:

[0...

Embodiment 2

[0127] Example 2: Diagnosis of a diagnostic kit for distinguishing healthy subjects, patients with metabolic syndrome or patients with colorectal cancer

[0128] 1. A diagnostic kit for colorectal cancer, which is used for the early diagnosis of colorectal cancer in healthy people or patients with metabolic syndrome, which contains standard products of diagnostic markers, and the diagnostic markers are isoleucine, tyrosine, benzene Alanine, tryptophan, glutamine-leucine, p-hydroxycinnamic acid or phosphatidylethanolamine PE (18:2(9Z,12Z) / P-18:0).

[0129] 2. A diagnostic kit for colorectal cancer, which is used for the early diagnosis of colorectal cancer in healthy people or patients with metabolic syndrome, which contains standards for diagnostic markers, including tyrosine and glutamine-leucine acid.

[0130] 3. A diagnostic kit for colorectal cancer, which is used for the early diagnosis of colorectal cancer in healthy people or patients with metabolic syndrome, which con...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of hydroxycinnamic acid or phosphatidylethanolamine in early diagnosis of colorectal cancer. In a validation set of specific embodiments, the accuracy for distinguishing healthy subjects and colorectal cancer patients by taking hydroxycinnamic acid or phosphatidylethanolamine PE (18:2 (9Z,12z) / P-18:0) as a marker can reach 85.4% and 98.5%, the accuracy for distinguishing metabolic syndrome patients and colorectal cancer patients by taking hydroxycinnamic acid or phosphatidylethanolamine PE (18:2 (9Z,12z) / P-18:0) as the marker can reach 92.3% and 99.0%. Ascan be seen, hydroxycinnamic acid or phosphatidylethanolamine PE (18:2 (9Z,12z) / P-18:0) has a high diagnosis accuracy for colorectal cancer, can be prepared to a diagnosis kit for colorectal cancer and be used for early diagnosis of colorectal cancer in healthy people or metabolic syndrome patients.

Description

technical field [0001] The invention belongs to the field of disease detection and diagnosis, and relates to the discovery and application of disease diagnostic markers, in particular to the application of metabolic markers in the early diagnosis of metabolic syndrome and colorectal cancer. Background technique [0002] Colorectal cancer is one of the common malignant tumors and has become one of the three major cancers in China, with a prevalence rate as high as 46.8 / 100,000, and 130,000 to 160,000 new cases each year. If colorectal cancer is detected early, the 5-year survival rate of patients can reach more than 90%; if it is not detected early enough that it has metastasized to other organs or tissues, the survival rate is only about 10%. Therefore, early diagnosis of colorectal cancer is very important to improve the survival rate of colorectal cancer patients. [0003] Patients with metabolic syndrome have a significantly higher probability of developing colorectal ca...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/574G01N30/96G01N30/72G01N30/04G01N30/06G01N30/86G01N30/88
CPCG01N30/04G01N30/06G01N30/72G01N30/8634G01N30/88G01N30/96G01N33/574G01N33/57446G01N33/57484G01N2030/045G01N2030/8813
Inventor 来茂德李健康齐炼文朱益民李菁王欢
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com